Alnylam Pharmaceuticals, Inc.

DUL.F·Frankfurt·Healthcare
Compare
201.80−2.40 (−1.18%)today
As of Oct 21, 7:40 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close204.20
Open205.20
Day range200.60205.20
52-week range173.50414.60
Off day high−1.66%
Off 52-week high−51.33%
Volume11.00
Avg. volume (3M)35.00
Market cap27.00B
EPS (TTM)5.08
Forward P/E-53.67
P/E ratio (TTM)39.72
Dividend yield—
Beta (5Y)0.27
Shares outstanding133.81M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin16.13%

Against its peers

Compare in full ›
DUL.F IONS ARWR BBIO ROIV 6855.HK
Market cap 27.00B 7.36B 8.31B 13.24B 26.58B 10.74B
P/E (TTM) 39.7 — — — — —
Forward P/E -53.7 -38.6 -11.8 -301.6 -21.4 -74.1
Price/book 22.4 16.7 17.8 -5.3 6.3 16.4
Dividend yield — — — — — —
1-year change −49.01% −36.50% +56.58% +26.88% +94.43% −52.27%
Today −1.18% −2.49% −0.14% +0.28% +5.38% −8.06%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All DUL.F news ›

From articles in the 4Search news index.

In the news

7mentions in 30 days
7with it in the headline
Negativesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.